Latest St. Jude Medical Stories
Industry-Leading Battery Life Reduces the Frequency of Replacement Surgery NATICK, Mass., May 10, 2013 /PRNewswire/ -- New data from 100,438 patients with Boston Scientific Corporation (NYSE:BSX) implantable cardiac defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) followed in the LATITUDE(TM)( )Patient Management System demonstrate the battery life of Boston Scientific single-chamber ICDs, dual-chamber ICDs and CRT-Ds are projected to last an...
CHICAGO, April 30, 2013 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for IBM, BIIB, STJ, NIHD, and ARCO. (Photo: http://photos.prnewswire.com/prnh/20120712/CG39046) To see what our analysts have discovered about these stocks read the InvestorsObserver's PriceWatch Alerts at http://www.investorsobserver.com/pr/42920131 (Note: You may have to copy this link into your browser then press the [ENTER] key.) Today's PriceWatch Alerts cover the following stocks:...
New ICD device technology is changing the CRM market for a population with heart disease on the rise. Vancouver, Canada (PRWEB) April 16, 2013 Heart failure affects over five million people annually in the U.S., and is the most costly cardiovascular illness with upwards of $30 billion spent on managing it each year. According to a new report by iData Research, the leading global authority in medical device and pharmaceutical market research, the U.S. cardiac rhythm management (CRM),...
Physicians Will Increasingly Favor High-End Products, but Reimbursement Cuts Will Stunt Market Potential, According to Millennium Research Group TORONTO, April 3, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, prices of interventional cardiology devices in Japan will see significant declines through 2021. The Japanese Ministry of Health, Labor and Welfare (MHLW) is implementing reimbursement cuts...
Consumer Lawyer Kendall Almerico comments on a New York Times report that the FDA has sent a strong warning letter to medical device manufacturer St. Jude Medical in which the governmental agency threatened to fine or take other punitive actions against the company for failing to address safety concerns about a widely used heart device component, the Durata defibrillator lead. Almerico notes that a malfunctioning Durata lead, a component that connects an implanted defibrillator to a...
LOS ANGELES, Feb. 9, 2013 /PRNewswire/ -- Product liability law firm TorkLaw continues to pursue litigation against St. Jude Medical on behalf of injured patients and their families. In December 2011, the Food and Drug Administration issued a Class 1 recall for the St. Jude Medical Riata leads after many adverse events were being reported in patients. Studies showed that the leads which connect the heart defibrillator to the heart were failing due to insulation problems referred to...
LONDON, February 8, 2013 /PRNewswire/ -- At the start of this year, a controversial feature of President Obama's Affordable Care Act (ACA) went into effect. Under the ACA, medical devices companies will have to pay new tax of 2.3% on gross sales. While medical devices companies have opposed the tax, saying it will hurt research and development activities, proponents of ACA say that it will ultimately benefit companies such as Hologic Inc. (NASDAQ: HOLX) and St. Jude Medical...
ALBANY, New York, February 5, 2013 /PRNewswire/ -- According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Renal Denervation Devices (Symplicity, EnligHTN, OneShot, V2, Paradise, TIVUS, Bullfrog, Surround Sound, Micro-Infusion, Ultrasound and Radiofrequency) Market - Global Industry Analysis, Size, Share, Growth, and Forecast, 2012 - 2021," the RDN devices market was USD 88.5 million in 2012 globally and is...
PHILADELPHIA, Dec. 7, 2012 /PRNewswire/ -- Barrack, Rodos & Bacine announces that it has filed a class action lawsuit in the United States District Court for the District of Minnesota, Freedman v. St. Jude Medical, Inc., et al., No. 12-03070-RHK-JJG, on behalf of purchasers of common stock of St. Jude Medical, Inc. (NYSE: STJ) during the period from October 17, 2012 through and including November 20, 2012 (the "Class Period"). The complaint charges St. Jude and its chief...
SAN DIEGO, Oct. 31, 2012 /PRNewswire/ -- Fish & Richardson scored a major victory for San Diego based Volcano Corporation in a patent trial regarding medical device technology used to diagnose heart problems. After less than 90 minutes of deliberation, a federal district court jury in Delaware found that Volcano did not infringe two patents asserted by St. Jude Medical Inc. and that another two St. Jude patents were invalid. A fifth St. Jude patent was declared not infringed by...
